Comparing two asthma inhalers for moderate asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests if a new combination inhaler (formoterol/fluticasone) works as well as an existing one (Alenia) for people with moderate asthma. You may be able to join if your asthma is stable and well controlled with your current treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 65 years old.
- You have been diagnosed with moderate asthma for at least 6 months and use a daily inhaler containing both a LABA and a low-dose steroid.
- Your asthma is well controlled (no recent flare-ups needing urgent care or steroid pills).
- You have had a breathing test showing that your lungs improve after using a rescue inhaler.
- You do not have other serious lung diseases, heart problems, or uncontrolled diabetes.
- You are not pregnant, breastfeeding, or planning to become pregnant during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a new albuterol inhaler works as well as the standard one for people with mild asthma. You'll breathe in a medicine that measures how your lungs respond, helping show the new inhaler is safe and effective.
This study tests a new combination inhaler (fluticasone propionate and albuterol) for people with asthma age 12 and older. It helps see if this inhaler works better than a placebo in controlling asthma symptoms and preventing attacks.
This study compares two versions of the common asthma rescue inhaler (salbutamol/albuterol) that use different propellants (the gas that pushes the medicine out). The goal is to see if the new propellant works as well as the current one. If you have mild asthma and are on a stable treatment plan, you may be able to join.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
Hear when a new Moderate Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.